Apimeds Pharmaceuticals US, Inc.
APUS
$2.20
-$0.07-3.08%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -160.64% | -48.17% | -78.73% | -476.73% | -- |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,750.28% | 62.63% | 8.88% | -27.98% | -- |
| Change in Net Operating Assets | -775.17% | 1,714.49% | 1,189.00% | 443.58% | -- |
| Cash from Operations | -245.92% | 44.36% | -16.85% | -217.25% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 393.90% | -- | 3,527.78% | -43.79% | -- |
| Total Debt Repaid | -194.04% | -- | -- | 100.00% | -- |
| Issuance of Common Stock | 1,032.99% | -- | -- | -94.50% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 999.91% | -41.97% | -68.37% | -80.99% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13,708.92% | -27.02% | -200.69% | -171.90% | -- |